Delivery Order SPE2DB22D3004-SPE2DB25FRV80
- Not listed
- The Defense Logistics Agency awarded a $16,211.55 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors on August 22, 2025, with an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price delivery order represents a pediatric and adult cardiovascular pharmaceutical supply supporting federal medical procurement needs. The contract is issued without set-aside designation, reflecting AmerisourceBergen's demonstrated capability...
- The Defense Logistics Agency awarded a delivery order valued at $8,331.84 to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Repatha 140 mg/ml SureClick auto-injectors. This firm fixed price delivery order, with an ultimate completion date of August 7, 2025, represents a pediatric or maintenance supply requirement for this specialty cardiovascular medication used to treat high cholesterol. The contract was competitively awarded with no set-aside designation and will be performed...
- The Defense Logistics Agency awarded a delivery order valued at $31,046.64 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors on September 10, 2025, with completion scheduled for September 11, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and is being performed at the contractor's Conshohocken, Pennsylvania location. The award represents a pediatric or adult cardiovascular pharmaceutical supply supporting federal medical...
- The Defense Logistics Agency awarded a $15,001.90 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, a pharmaceutical product used in cardiovascular disease management. This firm fixed-price delivery order, issued on September 4, 2025, with an ultimate completion date of September 5, 2025, represents a competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $2,270.22 to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, with an ultimate completion date of August 20, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger prime Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December...
- The Defense Logistics Agency awarded a $1,513.48 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, a specialty pharmaceutical product for cholesterol management. The contract was competitively awarded with no set-aside designation and carries a firm fixed price structure with an ultimate completion date of September 11, 2025. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $4,002.34 delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors. This is a firm fixed price, competitively awarded contract with a completion date of August 25, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA. The pharmaceutical product will be delivered to the vendor's primary location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $1,562.13 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors. This firm fixed-price delivery order, with an ultimate completion date of August 14, 2025, represents a pediatric or specialty pharmaceutical requirement fulfilled through AmerisourceBergen's established federal contract infrastructure. The award was made without a set-aside designation, indicating competitive...
- The Defense Logistics Agency awarded a delivery order valued at $4,165.68 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of August 12, 2025. This non-competitive delivery order represents a firm fixed-price transaction for pharmaceutical products to support federal medical supply needs. The award was issued on August 11, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency has awarded a delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, valued at $10,380.32 under a firm fixed price contract. The award was issued on August 6, 2025, with an ultimate completion date of August 7, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order carries no set-aside designation and was competitively awarded through the federal...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB25FRV80Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,735.70 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injector on August 5, 2025, with an ultimate completion date of August 6, 2025. This non-set-aside, competitively awarded delivery order utilizes firm fixed pricing and represents a pediatric cardiovascular medication supply to support federal medical procurement needs. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's contract portfolio with DLA demonstrates significant capability in fulfilling federal medical supply requirements across multiple therapeutic domains through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 8/5/25 |